Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Lingwei Meng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3374-1716; OpenAlex author ID A5101760932. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. [Advances in Surgical Treatment Following Conversion Therapy for Pancreatic Cancer]. Co-author DOI 10.12182/20250760201↗
  2. Laparoscopic Pancreaticoduodenectomy with Superior Mesenteric Vein Resection and Artificial Vascular Graft Reconstruction for Borderline Resectable Pancreatic … Co-author DOI 10.1007/s11605-020-04808-y↗
  3. The Effect of Age on Short- and Long-Term Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Laparoscopic Pancreaticoduodenectomy. Co-author DOI 10.1097/mpa.0000000000001620↗
  4. Preclinical pharmacodynamic evaluation of a new Src/FOSL1 inhibitor, LY-1816, in pancreatic ductal adenocarcinoma. First author DOI 10.1111/cas.13929↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bing Peng · 1 shared paper, 2025 · strength 0.42
  2. Bing Peng · 3 shared papers, 2019–2020 · strength 0.40
  3. Xin Wang · 1 shared paper, 2020 · strength 0.12
  4. He Cai · 1 shared paper, 2020 · strength 0.12
  5. Shengyong Yang · 1 shared paper, 2019 · strength 0.09
  6. Linli Li · 1 shared paper, 2019 · strength 0.09
  7. Wei Yang · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.